Condition: Major Depression · Sponsor: VA Office of Research and Development
The purpose of this multi-site randomized controlled trial is to evaluate the efficacy and risks of psilocybin for the treatment of depression in U.S. military Veterans with and without (±) concurrent posttraumatic stress disorder.
This description comes directly from the study's public registry record.
Lori L Davis, MD AB · (205) 554-3819 · lori.davis@va.gov
Anchal Ghera, MS · (205) 899-1273 · anchal.ghera@va.gov
Always discuss trial participation with your own doctor first.
| Birmingham VA Medical Center, Birmingham, AL | Birmingham, Alabama, United States | — |
| Tuscaloosa VA Medical Center, Tuscaloosa, AL | Tuscaloosa, Alabama, United States | — |
| VA Portland Health Care System, Portland, OR | Portland, Oregon, United States | — |
| Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA | Philadelphia, Pennsylvania, United States | — |
| VA Puget Sound Health Care System Seattle Division, Seattle, WA | Seattle, Washington, United States | — |
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.